Quipt Home Medical Corp.

Equities

QIPT

CA74880P1045

Healthcare Facilities & Services

Market Closed - Toronto S.E. Other stock markets 20:59:50 07/06/2024 BST			5-day change	1st Jan Change
4.41 ^CAD	+0.46%		-3.92%	-34.67%

05-20	Benchmark Trims Price Target on Quipt Home Medical to $9 From $10, Maintains Buy Rating	MT
05-17	Canaccord Genuity Adjusts Price Target on Quipt Home Medical to $8 From $9, Maintains Buy Rating	MT

Quipt Home Medical Corp. acquired 10% stake in DMEScripts LLC for $1.5 million.

August 13, 2023

Quipt Home Medical Corp. (TSX:QIPT) acquired 8.3% stake in DMEScripts LLC for $1.5 million on July 31, 2023.

Quipt Home Medical Corp. (TSX:QIPT) completed the acquisition of 8.3% stake in DMEScripts LLC on July 31, 2023.

Latest news about Quipt Home Medical Corp.

Benchmark Trims Price Target on Quipt Home Medical to $9 From $10, Maintains Buy Rating	05-20	MT
Canaccord Genuity Adjusts Price Target on Quipt Home Medical to $8 From $9, Maintains Buy Rating	05-17	MT
Raymond James Downgrades Quipt Home Medical to Underperform	05-17	MT
Transcript : Quipt Home Medical Corp., Q2 2024 Earnings Call, May 16, 2024	05-16
Quipt Home Medical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	05-15	CI
Quipt Home Medical Corp. Brief: Posts Adjusted EBITDA Margin of 23.3% as a % of Revenue	05-15	MT
Quipt Home Medical Corp. Brief: Revenue for Q2 2024 was US$64.0 million compared to $58.1 million for Q2 2023, representing a 10% increase	05-15	MT
Quipt Home Medical Corp. announces an Equity Buyback for 3,626,845 shares, representing 8.52% for CAD 5 million.	05-02	CI
Quipt Home Medical Announces 10% Stock Buyback	05-02	MT
Quipt Home Medical Corp. authorizes a Buyback Plan.	05-01	CI
Quipt Home Medical Maintained at Buy at Stifel GMP After Fiscal Q1 Results; Price Target Cut to C$10.50	02-16	MT
Transcript : Quipt Home Medical Corp., Q1 2024 Earnings Call, Feb 15, 2024	02-15
Quipt Home Medical Corp. Brief: Revenue for Q1 2024 was US$65.4 million compared to $40.8 million for Q1 2023; Net income (loss) for Q1 2024 was $(0.6) million, or ($0.01) per diluted share	02-14	MT
Quipt Home Medical Corp. Reports Earnings Results for the First Quarter Ended December 31, 2023	02-14	CI
North American Morning Briefing :Stock Futures -2-	02-14	DJ
Quipt Home Medical Corp. Brief: Shelf Prospectus and Registration Statement, when made final and effective, will enable Co to offer Up to C$300,000,000 of common shares, preferred shares, debt securities, warrants	12-27	MT
Quipt Home Medical Corp. Brief: Announced Filing of Preliminary Base Shelf Prospectus to Replace Recently Expired Base Shelf Prospectus	12-27	MT
Transcript : Quipt Home Medical Corp., Q4 2023 Earnings Call, Dec 19, 2023	12-19
Quipt Home Medical Corp. Up 3% In US After Hours Despite Q4 Net Loss; But Revs and Recurring Revs "Very Strong"	12-18	MT
Quipt Home Medical Corp. Brief: Adds Company "Maintains a conservative balance sheet" with net debt to Adjusted EBITDA leverage of 1.4x	12-18	MT
Quipt Home Medical Corp. Brief: Says Recurring Revenue for Q4 2023 was "Very Strong" and Exceeded 83% of total revenue, driven by growth in the Company's resupply platform	12-18	MT
Quipt Home Medical Corp. Brief: Revenue for Q4 2023 was US$62.5 million compared to $40.1 million for Q4 2022, representing a 56% increase	12-18	MT
Quipt Home Medical Corp. Brief: Net Loss for Q4 2023 was US($1.3) million, or ($0.03) per diluted share, as compared to $1.8 million, or $0.05 per diluted share for Q4 2022	12-18	MT
Quipt Home Medical Corp. Reports Earnings Results for the Fourth Quarter and Full Year Ended September 30, 2023	12-18	CI
North American Morning Briefing : Stock Futures -2-	12-18	DJ

Chart Quipt Home Medical Corp.

Duration

Period

More charts

Company Profile

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.

Sector

Healthcare Facilities & Services

Calendar

18/08/2024 - Q3 2024 Earnings Release (Projected)

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Quipt Home Medical Corp.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

4.41 CAD

Average target price

12 CAD

Spread / Average Target

+172.11%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
QUIPT HOME MEDICAL CORP.	-34.67%	136M
HCA HEALTHCARE, INC.	+24.66%	88.38B
CVS HEALTH CORPORATION	-21.76%	77.56B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+8.45%	26.97B
FRESENIUS SE & CO. KGAA	+7.94%	18.45B
LABCORP HOLDINGS INC.	-13.50%	16.57B
NATERA, INC.	+77.51%	13.65B
TENET HEALTHCARE CORPORATION	+76.96%	13.06B
FRESENIUS MEDICAL CARE AG	+4.72%	12.61B
DAVITA INC.	+36.67%	12.56B

Other Healthcare Facilities & Services